Literature DB >> 2480744

Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro.

M Hosoya1, S Shigeta, K Nakamura, E De Clercq.   

Abstract

A variety of antiviral compounds were examined for their inhibitory effect on measles (SSPE) virus plaque formation in VERO cells. The following compounds inhibited SSPE virus (strain Niigata-1) replication at concentrations that were significantly lower than their minimum cytotoxic concentrations: neplanocin A, neplanocin C, carbocyclic 3-deazaadenosine, 9-(trans-2', trans-3'-dihydroxycyclopent-4'-enyl)adenine, 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-3-deazaadenine, (RS)-3-adenin-9-yl-2-hydroxypropanoic acid isobutyl ester, carbodine, cyclopentenyl cytosine, 3-deazaguanine, pyrazofurin, ribavirin and 6-azauridine. As the most selective inhibitors of SSPE virus replication emerged pyrazofurin, 3-deazaguanine, 6-azauridine and ribavirin. These compounds were further examined for their relative potency against a number of measles (SSPE) virus strains. Their order of (decreasing) potency was pyrazofurin greater than 6-azauridine approximately 3-deazaguanine greater than ribavirin. Amantadine, inosiplex and glycyrrhizin, that were also included in these assays, did not show appreciable activity against any of the measles (SSPE) virus strains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480744     DOI: 10.1016/0166-3542(89)90072-7

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  19 in total

1.  High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.

Authors:  M Hosoya; S Shigeta; S Mori; A Tomoda; S Shiraishi; T Miike; H Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins.

Authors:  M Hosoya; J Balzarini; S Shigeta; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

3.  Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis.

Authors:  T Ishii; M Hosoya; S Mori; S Shigeta; H Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.

Authors:  George D Liatsos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

5.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

6.  The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope.

Authors:  Shinji Harada
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

7.  Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.

Authors:  Mitsuaki Hosoya; Shuichi Mori; Akemi Tomoda; Kenji Mori; Yukio Sawaishi; Hiroshi Kimura; Shiro Shigeta; Hitoshi Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay.

Authors:  Nadine C Gassner; Craig M Tamble; Jonathan E Bock; Naomi Cotton; Kimberly N White; Karen Tenney; Robert P St Onge; Michael J Proctor; Guri Giaever; Corey Nislow; Ronald W Davis; Phillip Crews; Theodore R Holman; R Scott Lokey
Journal:  J Nat Prod       Date:  2007-02-10       Impact factor: 4.050

9.  Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters.

Authors:  Y Honda; M Hosoya; T Ishii; S Shigeta; H Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

10.  Effects of protease inhibitors on replication of various myxoviruses.

Authors:  M Hosoya; S Matsuyama; M Baba; H Suzuki; S Shigeta
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.